Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRISM Registry: Pseudobulbar Affect Registry Series

NCT01366027 is registered in ClinicalTrials.gov with Avanir Pharmaceuticals as lead sponsor.

NCT NCT01366027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01366027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRISM Registry: Pseudobulbar Affect Registry Series
Lead sponsor
Avanir Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
May 31, 2011
Completion date
September 30, 2012
Enrollment
5,290 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, amyotrophic lateral sclerosis (als), multiple sclerosis (ms), parkinson's disease, stroke, traumatic brain injury